Transcription‐independent functions of p53 in DNA repair pathway selection

Recently discovered transcription‐independent features of p53 involve the choice of DNA damage repair pathway after PARylation, and p53's complex formation with phosphoinositide lipids, PI(4,5)P2. PARylation‐mediated rapid accumulation of p53 at DNA damage sites is linked to the recruitment of downstream repair factors and tumor suppression. This links p53's capability to sense damaged DNA in vitro and its relevant functions in cells. Further, PI(4,5)P2 rapidly accumulates at damage sites like p53 and complexes with p53, while it is required for ATR recruitment. These findings help explain how p53 and PI(4,5)P2 maintain genome stability by directing DNA repair pathway choice. Additionally, there is a strong correlation between p53 sequence homology, genome mutation rates as well as lifespans across various mammalian species. Further investigation is required to better understand the connections between genome stability, tumor suppression, longevity and the transcriptional‐independent function of p53.

[1]  May Yin Lee,et al.  Rapid recruitment of p53 to DNA damage sites directs DNA repair choice and integrity , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Suyong Choi,et al.  A p53-Phosphoinositide Signalosome Regulates Nuclear Akt Activation , 2021, bioRxiv.

[3]  David C. Jones,et al.  Somatic mutation rates scale with lifespan across mammals , 2021, Nature.

[4]  A. Tutt,et al.  Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance , 2021, Nature Communications.

[5]  S. Morganella,et al.  A practical framework and online tool for mutational signature analyses show intertissue variation and driver dependencies , 2020, Nature Cancer.

[6]  Bin Zhang,et al.  CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia. , 2019, The New England journal of medicine.

[7]  Suyong Choi,et al.  A nuclear phosphoinositide kinase complex regulates p53 , 2019, Nature Cell Biology.

[8]  Gregory McAllister,et al.  p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells , 2018, Nature Medicine.

[9]  J. Taipale,et al.  CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response , 2018, Nature Medicine.

[10]  M. Murphy,et al.  p53 orchestrates DNA replication restart homeostasis by suppressing mutagenic RAD52 and POLθ pathways , 2018, eLife.

[11]  G. Shivashankar,et al.  DNA damage causes rapid accumulation of phosphoinositides for ATR signaling , 2017, Nature Communications.

[12]  L. Wiesmüller,et al.  The C-terminal domain of p53 orchestrates the interplay between non-covalent and covalent poly(ADP-ribosyl)ation of p53 by PARP1 , 2017, Nucleic acids research.

[13]  N. Lowndes,et al.  A role for the p53 tumour suppressor in regulating the balance between homologous recombination and non-homologous end joining , 2016, Open Biology.

[14]  A. Strasser,et al.  p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa. , 2013, Cell reports.

[15]  Wei Gu,et al.  Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence , 2012, Cell.

[16]  X. Wang,et al.  p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. , 2003, Cancer research.

[17]  L. Wiesmüller,et al.  The C-terminal domain of p 53 orchestrates the interplay between non-covalent and covalent poly ( ADP-ribosyl ) ation of p 53 by PARP 1 , 2018 .